Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 8Multiple Myeloma 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Prostatic Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Inflammation 2Frailty 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Ventilator-Induced Lung Injury 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Postoperative Complications 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mucositis 1

Interventions

Paclitaxel 7Pemetrexed 3Cisplatin 3Carboplatin 3pembrolizumab 2durvalumab 2adavosertib 2Trastuzumab 2Radiotherapy 2Nivolumab 2FANG vaccine 2Docetaxel 2CP protocol 2Brachytherapy 2ulixertinib 1tucatinib 1trastuzumab biosimilar HLX02 1trametinib 1seribantumab 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1olaparib 1niraparib 1larotrectinib 1ipatasertib 1gedatolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Uterine Neoplasms × Ascorbic Acid × Clear all
NCT00284427 2016-02-10

Safety of Antioxidants During GYN Cancer Care

University of Kansas Medical Center

Phase 2 Completed
25 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡